3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions

NCT06217081 · Status: TERMINATED · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2026-07-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to generate safety and performance data for 3M™ Topical Tissue Adhesive. Enrolled subjects with qualifying trauma lacerations or surgical incisions will be randomized to receive 3M™ Topical Tissue Adhesive or Histoacryl® Blue Topical Skin Adhesive with follow-up visits at 10 days and 30 days after application of tissue adhesive.

Conditions

  • Trauma-related Wound
  • Surgical Incision
  • Surgical Wound
  • Laceration

Interventions

DEVICE

3M Topical Tissue Adhesive

Application of investigational topical tissue adhesive to trauma laceration or surgical incision.

DEVICE

Histoacryl® Blue Topical Skin Adhesive

Application of control topical tissue adhesive to trauma laceration or surgical incision.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • The University of Texas Health Science Center at San Antonio

    collaborator OTHER
  • 3M

    collaborator INDUSTRY
  • Solventum US LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-28
Primary Completion
2025-06-24
Completion
2025-06-24

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06217081 on ClinicalTrials.gov